Form 4: Mustang Bio CEO Manuel Litchman Reports Stock Transactions

CEO Manuel Litchman reports relinquishing shares to cover tax liabilities from vesting restricted stock units and acquiring shares through the Employee Stock Purchase Plan.

Summary

• On April 24, 2022, Manuel Litchman relinquished 1,248 shares of common stock at $12.15 to cover tax liabilities associated with vesting restricted stock units, resulting in a holding of 80,992 shares.
• On April 24, 2023, Litchman relinquished 1,572 shares of common stock at $4.21 to cover tax liabilities from vesting restricted stock units, resulting in a holding of 79,420 shares.
• The reported holdings include 3,975 shares acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2023, and September 1, 2023.
• The amount of common stock reflected on this Form 4 has been adjusted to reflect a 1-for-15 reverse stock split that occurred subsequent to this transaction.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports routine stock transactions related to tax obligations and employee stock purchase plan.

Positives

• The CEO's participation in the Employee Stock Purchase Plan indicates confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be a signal to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the CEO's holdings.

Key Dates

Keywords

Form 4, insider trading, stock transactions, Manuel Litchman, Mustang Bio, MBIO, CEO, stock options, restricted stock units, employee stock purchase plan